To Get More Information on Glycomics Market - Request Sample Report
Glycomics Market was valued at USD 1.68 billion in 2023 and is expected to reach USD 5.33 billion by 2032, growing at a CAGR of 13.76% from 2024-2032.
The glycomics market is undergoing significant growth following advances in biotechnology and the transition to personalized medicine, which have opened new avenues for understanding complex biological processes. In 2023 alone, global pharmaceutical R&D spending exceeded USD 301 billion, while more than 5,500 companies were actively involved in R&D pipelines, indicating the commitment of the healthcare sector to innovation. This focus on precision medicine and early diagnosis has placed a greater focus on glycan-based biomarkers and targeted therapy, through significant investment opportunities from established firms and agile startups competing to unlock the new therapeutic and diagnostic possibilities hidden within glycomics.
This is driven by the increased interest in glycan-based biomarkers and targeted therapies due to the focus on precision medicine and early diagnosis within the healthcare industry. Pharmaceutical companies want to use glycomics to improve aspects like drug development, effectiveness, and specificity. Emerging technologies, such as the newly developed AI model "CandyCrunch," which is a dilated residual neural network predicting glycan structures from raw LC-MS/MS data with an astonishing accuracy of 87.7% in seconds, are revolutionizing the analysis of glycomics into a quicker and more straightforward process, thus much more broadly applicable to biosciences.
Collaboration between academia and industry is improving the promise of glycomics, drawing both well-established companies and agile start-ups in with innovative and high-throughput solutions that provide increasing market competition. Among those considered most promising advances for the glycomics field of the future are AI-driven glycan analysis, automated workflows, and improvements in mass spectrometry. Regulatory frameworks that support precision medicine and advanced biological research are likely to speed the adoption of glycomics, providing an investment-friendly environment for new engagements. This is expected to establish glycomics as a critical tool in healthcare and life sciences, further propelling growth and innovation in the industry.
DRIVERS
Rising Incidence of Chronic Diseases as a Catalyst for Growth in the Glycomics Market
Chronic diseases such as cancer, diabetes, and cardiovascular conditions are creating a huge demand for advanced diagnostics and targeted therapies. Therefore, patients suffering from such diseases have a significant impact on the glycomics market, given that China accounts for 140.9 million out of total global diabetes cases at 26.3%. Better diagnostic tools and treatments require improved glycomics studies on glycans and their role in diseases to further the precision medicine movement. It serves in identifying biomarkers and advancing targeted treatments of diseases. Increasing demand for high-technology glycan analysis tools coupled with supportive regulatory policies is expected to propel the market for glycomics at an exceptional growth rate. The said trend will continue to attract massive investments and make glycomics an indispensable area of healthcare innovation that ensures early diagnosis and targeted treatment of chronic diseases. Glycomics will be continuously evolving in developing its further utilization to improve global healthcare outcomes.
Increased Applications of Glycomics in Diagnostics Fueling Market Demand for Advanced Technologies
The growing focus on glycan biomarkers for diagnostics is driving the increased demand for glycomics technologies in laboratories and clinics. Early detection and monitoring of diseases like cancer, diabetes, and infections require highly sensitive glycan-based approaches, prompting the healthcare industry to adopt these solutions. Advances in high-throughput screening technology and supportive regulatory frameworks are making glycan analysis more accessible and efficient. This shift is creating significant market opportunities for glycomics tool companies while intensifying competition as new players enter the field. As the need for innovative diagnostic technologies continues to rise, both research and clinical testing sectors are expected to experience substantial growth. The expanding applications of glycomics in disease detection and monitoring are positioning it as a key driver in the future of healthcare diagnostics, offering enhanced precision and personalization in medical treatments.
RESTRAINTS
Regulatory Challenges Impeding Market Growth for Glycomics-Based Diagnostics
Strict regulations around the approval of novel glycomics-based diagnostic tools are a significant market growth inhibitor, and these could delay widespread acceptance of these tools. Validation processes for such tests due to safety, effectiveness, and reliability concerns are lengthy and costly and often deter new product development and commercialization. Strict regulations coupled with the requirement of broad clinical trials essentially create hurdles for businesses entering glycomics technology streams. These challenges delay product introductions and add to costs, thereby reducing opportunities for smaller firms and slowing the rate of overall market growth. The time and resources required for regulatory compliance can discourage innovation and slow the acceptance of glycomics-based diagnostics into clinical settings. It is, therefore imperative that these regulatory challenges are crossed to speed up the introduction of advanced glycomics solutions and its integration into the health care system to benefit from enhanced disease detection and curative therapies.
BY APPLICATION
Drug Discovery & Development Segment dominated the Glycomics market with the highest revenue share of about 45% in 2023. These results reflect the high demand for targeted drug development and increasing dependency on glycomics for identifying novel therapeutic targets, mainly in cancer and metabolic disorders. Further technological advancements still are a proving ground to strengthen this segment and ensure continued market leadership while attracting further investment.
The diagnostics segment is expected to grow at the highest CAGR of 15.36% during 2024-2032, based on innovations in the early detection of diseases and higher adoption of glycan biomarkers. Indeed, the philosophy of precision medicine could sustain higher competition dynamics, rising investment momentum, and broader application of a wide gamut of personalized diagnostic tools.
Do You Need any Customization Research on Glycomics Market - Enquire Now
BY PRODUCT
The Enzymes segment dominated the glycomics market, with a revenue share of about 34% in 2023, boosted by a well-established demand for enzyme-based solutions in glycan analysis and synthesis. Enzymes are crucial in a study because their ability to modify and characterize glycans with precision makes them applicable in research to therapeutic use. As technological advances improve the accuracy and efficiency of enzyme-based processes further, this segment is likely to remain prominent, with more investment being created and attracted to fuel its growth
The Instruments segment is expected to grow at the fastest CAGR of 15.53% between 2024 and 2032 on account of the rising need for advanced analytical tools in glycomics research. Innovative applications such as mass spectrometry, chromatography, and automated systems have been constantly making glycan analysis more efficient and accessible. The growth in this aspect will probably spur competition, drive innovation, and unlock new market opportunities with higher usage of both academic and clinical applications.
BY END USE
Academic & Research Institutes Segment- dominated the glycomics market with the highest revenue share of about 42% in 2023, mainly driven by the demand for high-end glycomics research. These institutions are centers where technological innovation is furthered and glycan structures associated with biological processes are understood. Being well established and with a stream of funding, they maintained their leadership position in the market. The leadership has driven further research and been a platform for setting future progress tracks in glycomics.
Biopharmaceutical Companies Segment is expected to grow at the highest CAGR of about 15.61% from 2024-2032 with the emergence of drug discovery and development with glycomics. Owing to the increased concentration on the horizon of personalized medicine and targeted therapies, biopharmaceutical companies are significantly investing in glycomics research. This trend is supposed to enhance competition, foster more collaborations, and invite greater investment. In this case, the segment will lead to alteration in the development of drugs and healthcare solutions.
The North America region dominated the glycomics market with the highest revenue share of about 43% in 2023, driven by strong demand for advanced glycomics technologies and a well-established infrastructure for research and development. The region has a stronghold on glycomics due to robust investment by major market players and considerable government and private investments. It will continue as North America will still be a leader for advanced research and commercial applications that will influence world market trends and add further competitiveness.
Europe Region is expected to grow at the fastest CAGR of about 15.43% from 2024-2032, on account of increased investment in research, innovation, and increased adoption of glycomics-based diagnostics and therapies. Emerging trends in personalised medicine and trans-sector collaborative efforts open new opportunities for further market growth. Such growth will spur more regional competition and bring new entrants into the glycomics market, triggering further investments in this field, and changing the dynamics of Europe's presence in the global market and accelerating innovation.
LATEST NEWS-
On January 30, 2024, Vector Laboratories and Navinci Diagnostics announced a partnership to develop biomarker discovery techniques focused on identifying protein glycosylation in tissue samples, advancing precision diagnostics.
In 2024, Bruker advanced glycoproteomics with the timsTOF Ultra 2 platform and its Glyco-PASEF method, which, enhanced by ENRICHplus, significantly increases the accuracy and depth of glycopeptide analysis, providing valuable insights into glycobiology.
KEY PLAYERS
Thermo Fisher Scientific, Inc. (Pierce Glycoprotein Isolation Kit, GlycanPac AXH-1 Column)
Merck KGaA (GlycanReactor, Glycan Standards)
Agilent Technologies Inc. (6545XT AdvanceBio LC/Q-TOF, 1260 Infinity II Glycan Analysis System)
Bruker (MaXis 4G UHPLC-QTOF Mass Spectrometer, glycanPro Software)
New England Biolabs (NEBNext Ultra II DNA Library Prep Kit for Illumina, GlycoWorks RapiFluor-MS Kit)
Shimadzu Corporation (LCMS-8045 Mass Spectrometer, Nexera UHPLC System)
Waters Corporation (ACQUITY UPLC Glycan Separation System, Xevo TQ-S Micro Mass Spectrometer)
Takara Bio Inc. (SMARTer GlycoSeq Sequencing Kit, GlycoScreen Kit)
Asparia Glycomics (Glycan Mapping Kit, GlycoSeq Glycosylation Profiling Service)
RayBiotech Life, Inc. (Glycan Assay Kit, Custom Glycan Profiling Service)
Danaher Corporation (Cytation 5 Cell Imaging Multi-Mode Reader, GlycanChip)
Dextra Laboratories Limited (Glycan Standards, GlycoConnect Platform)
AbbVie (GlycoPro Glycan Analysis System, VeroCell Glycan Profiling Kit)
GlycoMimetics, Inc. (GMI-1271, GlycoMimetics Glycan Profiling Service)
FMC Corporation (Glycosylation Screening Reagents, GlycoRite Enzyme)
Biocrates Life Sciences AG (Targeted Glycomics Panel, AbsoluteIDQ p180 Kit)
Exiqon (LNA microRNA Array, Glycomics Profiling Service)
Genentech (GlycoMAb Monoclonal Antibodies, GlycoFIT Technology Platform)
GlycoNet (Glycan Analysis Services, GlycoBiology Research Products)
Chugai Pharmaceutical Co., Ltd. (Glycosylation Assay Kit, GlycoPro Therapeutic Antibodies)
Vector Laboratories (Glyco-Ta Glycan Labeling Kits, VECLECTIN Lectin Conjugates)
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | USD 1.68 Billion |
| Market Size by 2032 | USD 5.33 Billion |
| CAGR | CAGR of 13.76% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Enzymes, Kits, Reagents, Instruments) • By Application (Drug Discovery & Development, Diagnostics, Others) • By End-Use (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Biopharmaceutical Companies, CROs) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Thermo Fisher Scientific, Inc., Merck KGaA, Agilent Technologies Inc., Bruker, New England Biolabs, Shimadzu Corporation, Waters Corporation, Takara Bio Inc., Asparia Glycomics, RayBiotech Life, Inc., Danaher Corporation, Dextra Laboratories Limited, AbbVie, GlycoMimetics, Inc., FMC Corporation, Biocrates Life Sciences AG, Exiqon, Genentech, GlycoNet, Chugai Pharmaceutical Co., Ltd., Vector Laboratories |
| Key Drivers | • Rising Incidence of Chronic Diseases as a Catalyst for Growth in the Glycomics Market • Increased Applications of Glycomics in Diagnostics Fueling Market Demand for Advanced Technologies |
| RESTRAINTS | • Regulatory Challenges Impeding Market Growth for Glycomics-Based Diagnostics |
Glycomics Market was valued at USD 1.68 billion in 2023 and is expected to reach USD 5.33 billion by 2032, growing at a CAGR of 13.76% from 2024-2032.
Glycomics plays a critical role in drug discovery, diagnostics, and personalized medicine, enhancing the understanding of glycans in health and disease.
Enzymes were the top revenue-generating product, with a 34% market share in 2023.
North America led the market with a 43% revenue share.
Europe is expected to grow at a CAGR of 15.43%, driven by increased research funding, innovation in diagnostics, and a focus on personalized medicine.
Table of Contents:
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Prescription Trends, (2023), by Region
5.3 Drug Volume: Production and usage volumes of pharmaceuticals
5.4 Healthcare Spending: Expenditure data by government, insurers, and out-of-pocket by patients
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and supply chain strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Glycomics Market Segmentation, by Product
7.1 Chapter Overview
7.2 Enzymes
7.2.1 Enzymes Market Trends Analysis (2020-2032)
7.2.2 Enzymes Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.3 Glycosidases
7.2.3.1 Glycosidases Market Trends Analysis (2020-2032)
7.2.3.2 Glycosidases Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.4 Neuraminidases
7.2.4.1 Neuraminidases Market Trends Analysis (2020-2032)
7.2.4.2 Neuraminidases Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.5 Glycosyltransferases
7.2.5.1 Glycosyltransferases Market Trends Analysis (2020-2032)
7.2.5.2 Glycosyltransferases Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.6 Sialyltransferases
7.2.6.1 Sialyltransferases Market Trends Analysis (2020-2032)
7.2.6.2 Sialyltransferases Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.7 Others
7.2.7.1 Others Market Trends Analysis (2020-2032)
7.2.7.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Kits
7.3.1 Kits Market Trends Analysis (2020-2032)
7.3.2 Kits Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.3 Glycan Labeling Kits
7.3.3.1 Glycan Labeling Kits Market Trends Analysis (2020-2032)
7.3.3.2 Glycan Labeling Kits Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.4 Glycan Purification Kits
7.3.4.1 Glycan Purification Kits Market Trends Analysis (2020-2032)
7.3.4.2 Glycan Purification Kits Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.5 Glycan Release Kits
7.3.5.1 Glycan Release Kits Market Trends Analysis (2020-2032)
7.3.5.2 Glycan Release Kits Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.6 Others
7.3.6.1 Others Market Trends Analysis (2020-2032)
7.3.6.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Reagents
7.4.1 Reagents Market Trends Analysis (2020-2032)
7.4.2 Reagents Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4.3 Glycoproteins
7.4.3.1 Glycoproteins Market Trends Analysis (2020-2032)
7.4.3.2 Glycoproteins Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4.4 Monosaccharides
7.4.4.1 Monosaccharides Market Trends Analysis (2020-2032)
7.4.4.2 Monosaccharides Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4.5 Oligosaccharides
7.4.5.1 Oligosaccharides Market Trends Analysis (2020-2032)
7.4.5.2 Oligosaccharides Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4.6 Others
7.4.6.1 Others Market Trends Analysis (2020-2032)
7.4.6.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
7.5 Instruments
7.5.1 Instruments Market Trends Analysis (2020-2032)
7.5.2 Instruments Market Size Estimates and Forecasts to 2032 (USD Billion)
7.5.3 Mass Spectrometers
7.5.3.1Mass Spectrometers Market Trends Analysis (2020-2032)
7.5.3.2 Mass Spectrometers Market Size Estimates and Forecasts to 2032 (USD Billion)
7.5.4 HPLC
7.5.4.1 HPLC Market Trends Analysis (2020-2032)
7.5.4.2 HPLC Market Size Estimates and Forecasts to 2032 (USD Billion)
7.5.5 MALDI-TOF
7.5.5.1 MALDI-TOF Market Trends Analysis (2020-2032)
7.5.5.2 MALDI-TOF Market Size Estimates and Forecasts to 2032 (USD Billion)
7.5.6 Array Systems
7.5.6.1 Array Systems Market Trends Analysis (2020-2032)
7.5.6.2 Array Systems Market Size Estimates and Forecasts to 2032 (USD Billion)
7.5.7 Others
7.5.7.1 Others Market Trends Analysis (2020-2032)
7.5.7.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Glycomics Market Segmentation, by Application
8.1 Chapter Overview
8.2 Drug Discovery & Development
8.2.1 Drug Discovery & Development Market Trends Analysis (2020-2032)
8.2.2 Drug Discovery & Development Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Diagnostics
8.3.1 Diagnostics Market Trends Analysis (2020-2032)
8.3.2 Diagnostics Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Others
8.4.1 Others Market Trends Analysis (2020-2032)
8.4.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Glycomics Market Segmentation, by End Use
9.1 Chapter Overview
9.2 Academic & Research Institutes
9.2.1 Academic & Research Institutes Market Trends Analysis (2020-2032)
9.2.2 Academic & Research Institutes Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Pharmaceutical & Biotechnology Companies
9.3.1 Pharmaceutical & Biotechnology Companies Market Trends Analysis (2020-2032)
9.3.2 Pharmaceutical & Biotechnology Companies Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Biopharmaceutical Companies
9.4.1 Biopharmaceutical Companies Market Trends Analysis (2020-2032)
9.4.2 Biopharmaceutical Companies Market Size Estimates and Forecasts to 2032 (USD Billion)
9.5 CROs
9.5.1 CROs Market Trends Analysis (2020-2032)
9.5.2 CROs Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Glycomics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.2.3 North America Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.4 North America Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.5 North America Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.6.2 USA Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.6.3 USA Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.7.2 Canada Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.7.3 Canada Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.8.2 Mexico Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.8.3 Mexico Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe Glycomics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.1.3 Eastern Europe Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.4 Eastern Europe Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.5 Eastern Europe Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.3.1.6 Poland
10.3.1.6.1 Poland Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.6.2 Poland Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.6.3 Poland Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.3.1.7 Romania
10.3.1.7.1 Romania Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.7.2 Romania Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.7.3 Romania Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.3.1.8 Hungary
10.3.1.8.1 Hungary Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.8.2 Hungary Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.8.3 Hungary Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.3.1.9 Turkey
10.3.1.9.1 Turkey Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.9.2 Turkey Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.9.3 Turkey Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.10.2 Rest of Eastern Europe Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.10.3 Rest of Eastern Europe Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe Glycomics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.2.3 Western Europe Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.4 Western Europe Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.5 Western Europe Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.3.2.6 Germany
10.3.2.6.1 Germany Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.6.2 Germany Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.6.3 Germany Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.3.2.7 France
10.3.2.7.1 France Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.7.2 France Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.7.3 France Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.3.2.8 UK
10.3.2.8.1 UK Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.8.2 UK Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.8.3 UK Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.3.2.9 Italy
10.3.2.9.1 Italy Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.9.2 Italy Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.9.3 Italy Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.3.2.10 Spain
10.3.2.10.1 Spain Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.10.2 Spain Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.10.3 Spain Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.11.2 Netherlands Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.11.3 Netherlands Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.12.2 Switzerland Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.12.3 Switzerland Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.3.2.13 Austria
10.3.2.13.1 Austria Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.13.2 Austria Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.13.3 Austria Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.14.2 Rest of Western Europe Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.14.3 Rest of Western Europe Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific Glycomics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.4.3 Asia Pacific Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.4 Asia Pacific Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.5 Asia Pacific Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.4.6 China
10.4.6.1 China Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.6.2 China Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.6.3 China Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.4.7 India
10.4.7.1 India Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.7.2 India Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.7.3 India Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.8.2 Japan Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.8.3 Japan Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.9.2 South Korea Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.9.3 South Korea Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.4.10 Vietnam
10.4.10.1 Vietnam Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.10.2 Vietnam Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.10.3 Vietnam Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.4.11 Singapore
10.4.11.1 Singapore Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.11.2 Singapore Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.11.3 Singapore Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.4.12 Australia
10.4.12.1 Australia Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.12.2 Australia Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.12.3 Australia Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.13.2 Rest of Asia Pacific Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.13.3 Rest of Asia Pacific Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East Glycomics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.1.3 Middle East Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.4 Middle East Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.5 Middle East Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.5.1.6 UAE
10.5.1.6.1 UAE Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.6.2 UAE Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.6.3 UAE Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.5.1.7 Egypt
10.5.1.7.1 Egypt Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.7.2 Egypt Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.7.3 Egypt Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.8.2 Saudi Arabia Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.8.3 Saudi Arabia Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.5.1.9 Qatar
10.5.1.9.1 Qatar Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.9.2 Qatar Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.9.3 Qatar Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.10.2 Rest of Middle East Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.10.3 Rest of Middle East Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa Glycomics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.2.3 Africa Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.4 Africa Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.5 Africa Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.5.2.6 South Africa
10.5.2.6.1 South Africa Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.6.2 South Africa Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.6.3 South Africa Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.7.2 Nigeria Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.7.3 Nigeria Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.8.2 Rest of Africa Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.8.3 Rest of Africa Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Glycomics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.6.3 Latin America Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.4 Latin America Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.5 Latin America Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.6.2 Brazil Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.6.3 Brazil Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.7.2 Argentina Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.7.3 Argentina Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.6.8 Colombia
10.6.8.1 Colombia Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.8.2 Colombia Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.8.3 Colombia Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America Glycomics Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.9.2 Rest of Latin America Glycomics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.9.3 Rest of Latin America Glycomics Market Estimates and Forecasts, by End Use (2020-2032) (USD Billion)
11. Company Profiles
11.1 Thermo Fisher Scientific, Inc.
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Products/ Services Offered
11.1.4 SWOT Analysis
11.2 Merck KGaA
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Products/ Services Offered
11.2.4 SWOT Analysis
11.3 Agilent Technologies Inc.
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Products/ Services Offered
11.3.4 SWOT Analysis
11.4 Bruker
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Products/ Services Offered
11.4.4 SWOT Analysis
11.5 New England Biolabs
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Products/ Services Offered
11.5.4 SWOT Analysis
11.6 Shimadzu Corporation
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Products/ Services Offered
11.6.4 SWOT Analysis
11.7 Waters Corporation
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Products/ Services Offered
11.7.4 SWOT Analysis
11.8 Takara Bio Inc.
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Products/ Services Offered
11.8.4 SWOT Analysis
11.9 Asparia Glycomics
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Products/ Services Offered
11.9.4 SWOT Analysis
11.10 RayBiotech Life, Inc.
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Products/ Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments:
By Product
Enzymes
Glycosidases
Neuraminidases
Glycosyltransferases
Sialyltransferases
Others
Kits
Glycan Labeling Kits
Glycan Purification Kits
Glycan Release Kits
Others
Reagents
Glycoproteins
Monosaccharides
Oligosaccharides
Others
Instruments
Mass Spectrometers
HPLC
MALDI-TOF
Array Systems
Others
By Application
Drug Discovery & Development
Diagnostics
Others
By End-use
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Biopharmaceutical Companies
CROs
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The Interactive Patient Engagement Solutions Market size was valued USD 22.6 Bn by 2023, & will reach $83.80 Bn by 2031, with CAGR of 17.8% by 2024-2031.
The Portable Ultrasound Market size was USD 2678.60 Million in 2023 and is expected to reach USD 7481.55 Million by 2031 and grow at a CAGR of 13.7% over the forecast period of 2024-2031.
The Medical Device Security Market was valued at USD 6.6 Bn in 2023 and is expected to reach USD 14.2 Bn by 2032, growing at a CAGR of 8.9% from 2024 to 2032.
The 3D Printing Medical Devices Market Size was valued at USD 2.93 billion in 2023 and is expected to reach USD 10.67 billion by 2031 and grow at a CAGR of 17.5% over the forecast period 2024-2031.
The U.S. Healthcare Payer Services Market Size was valued at USD 34.29 Billion in 2023 and is witness to reach USD 65.31 Billion by 2032 and grow at a CAGR of 7.74% over the forecast period 2024-2032.
The Gene Synthesis Market size was valued at USD 2.28 billion in 2023 and is expected to grow to USD 9.64 billion by 2032 and grow at a CAGR of 17.41% over the forecast period of 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
